Neutrophil-to-lymphocyte ratio after pazopanib treatment predicts response in patients with advanced soft-tissue sarcoma.
Kobayashi H, Okuma T, Oka H, Hirai T, Ohki T, Ikegami M, Sawada R, Shinoda Y, Akiyama T, Sato K, Abe S, Kawano H, Goto T, Tanaka S.
Kobayashi H, et al. Among authors: ikegami m.
Int J Clin Oncol. 2018 Apr;23(2):368-374. doi: 10.1007/s10147-017-1199-6. Epub 2017 Oct 31.
Int J Clin Oncol. 2018.
PMID: 29086877